| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.006 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.39 | 0.008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.009 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.34 | 0.01 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |